Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# INCB 8721 RVT-901: A Long-Term Open-Label Non-Randomized Study to Evaluate the Safety of 100 and 200mg Reverset? (RVT) in HIV-Infected Antiretroviral Therapy-Experienced Subjects When Used in Combination with Other Antiretroviral Agents
Palella Jr, Frank Joseph
(PD/PI)
Medicine, Infectious Diseases Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/7/05
→
8/6/08
Funding
Quintiles, Inc.
(INCB 8721 RVT-901)
Incyte Corporation
(INCB 8721 RVT-901)
View all
View less